L-carnitine treatment in incident hemodialysis patients: The multicenter, randomized, double- blinded, placebo-controlled CARNIDIAL trial

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 11, 2012, Pages 1836-1842

  Mercadal, Lucile ^a   Coudert, Mathieu ^a   Vassault, Anne ^a   Pieroni, Laurence ^b   Debure, Alain ^b   Ouziala, Messaoud ^b   Depreneuf, Hélène ^c   Fumeron, Christine ^c   Servais, Aude ^d   Bassilios, Nader ^e   Bécart, Jacques ^e   Assogba, Ubald ^f   Allouache, Mahmoud ^g   Bouali, Boussad ^g   Luong, Nhan ^g   Dousseaux, Marie Paul ^a   Montcel, Sophie Tezenas du ^a   Deray, Gilbert ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c CMC Pantin   (France)

^d Association pour l'Utilisation du Rein Artificiel   (France)

^e Clinique de Turin   (France)

^f Clinique des Mousseaux   (France)

^g INSTITUT MUTUALISTE MONTSOURIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALCIUM; CARNITINE; CHOLESTEROL; FERRITIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; TRIACYLGLYCEROL;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CARNITINE DEFICIENCY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALNUTRITION; MULTICENTER STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; THERAPY RESISTANCE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

CARNITINE; DOUBLE-BLIND METHOD; DRUG RESISTANCE; ERYTHROPOIETIN; HUMANS; MULTIVARIATE ANALYSIS; RECOMBINANT PROTEINS; RENAL DIALYSIS;

EID: 84869143848     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.12431211     Document Type: Article

References (28)

1. Fornasini G, Upton RN, Evans AM: A pharmacokinetic model for L-carnitine in patients receiving haemodialysis. Br J Clin Pharmacol 64: 335-345, 2007
2. Vernez L, Dickenmann M, Steiger J, Wenk M, Krähenbühl S: Effect of L-carnitine on the kinetics of carnitine, acylcarnitines and butyrobetaine in long-term haemodialysis. Nephrol Dial Transplant 21: 450-458, 2006
3. Bartel LL, Hussey JL, Shrago E: Perturbation of serum carnitine levels in human adults by chronic renal disease and dialysis therapy. Am J Clin Nutr 34: 1314-1320, 1981
4. Sakurauchi Y, Matsumoto Y, Shinzato T, Takai I, Nakamura Y, Sato M, Nakai S, Miwa M, Morita H, Miwa T, Amano I, Maeda K: Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients. Am J Kidney Dis 32: 258-264, 1998
5. Aguilar-Kitsu A, Ibarra-Cazares P, Mendoza-Guevara L, Villasis-Keever MA, Perez Andrade ME, Castillo-Romero L, Morales-Nava A, Rodriguez-Leyva F, Sanchez-Barbosa L: Frequency of low carnitine levels in children on dialysis. Adv Perit Dial 22: 208-210, 2006
6. Debska-Slizień A, Kawecka A, Wojnarowski K, Zadrony D, Kunicka D, Kró l E, Lysiak-Szydłowska W, Rutkowski B: Carnitine content in different muscles of patients receiving maintenance hemodialysis. J Ren Nutr 17: 275-281, 2007
7. Evans AM, Faull RJ, Nation RL, Prasad S, Elias T, Reuter SE, Fornasini G: Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease. Kidney Int 66: 1527-1534, 2004
8. Duranay M, Akay H, Yilmaz FM, Şeneş M, Tekeli N, Yücel D: Effects of L-carnitine infusions on inflammatory and nutritional markers in haemodialysis patients. Nephrol Dial Transplant 21: 3211-3214, 2006
9. Savica V, Santoro D, Mazzaglia G, Ciolino F, Monardo P, Calvani M, Bellinghieri G, Kopple JD: L-carnitine infusions may suppress serum C-reactive protein and improve nutritional status in maintenance hemodialysis patients. J Ren Nutr 15: 225-230, 2005
10. Calò LA, Pagnin E, Davis PA, Semplicini A, Nicolai R, Calvani M, Pessina AC: Antioxidant effect of L-carnitine and its short chain esters: Relevance for the protection from oxidative stress related cardiovascular damage. Int J Cardiol 107: 54-60, 2006
11. Matsumura M, Hatakeyama S, Koni I, Mabuchi H: Effect of Lcarnitine and palmitoyl-L-carnitine on erythroid colony formation in fetal mouse liver cell culture. Am J Nephrol 18: 355-358, 1998
12. Kitamura Y, Satoh K, Satoh T, Takita M, Matsuura A: Effect of Lcarnitine on erythroid colony formation in mouse bone marrow cells. Nephrol Dial Transplant 20: 981-984, 2005
13. Signorelli SS, Fatuzzo P, Rapisarda F, Neri S, Ferrante M, Oliveri Conti G, Fallico R, Di Pino L, Pennisi G, Celotta G, Massimiliano A: A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis. Drugs Aging 23: 263-270, 2006
14. Arduini A, Bonomini M, Clutterbuck EJ, Laffan MA, Pusey CD: Effect of L-carnitine administration on erythrocyte survival in haemodialysis patients. Nephrol Dial Transplant 21: 2671-2672, 2006
15. Kooistra MP, Struyvenberg A, van Es A: The response to recombinant human erythropoietin in patients with the anemia of end-stage renal disease is correlated with serum carnitine levels. Nephron 57: 127-128, 1991
16. Matsumura M, Hatakeyama S, Koni I, Mabuchi H, Muramoto H: Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients. Nephron 72: 574-578, 1996
17. Labonia WD: L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin. Am J Kidney Dis 26: 757-764, 1995
18. Caruso U, Leone L, Cravotto E, Nava D: Effects of L-carnitine on anemia in aged hemodialysis patients treated with recombinant human erythropoietin: a pilot study. Dial Transplant 27: 499-506, 1998
19. Kletzmayr J, Mayer G, Legenstein E, Heinz-Peer G, Leitha T, Hörl WH, Kovarik J: Anemia and carnitine supplementation in hemodialyzed patients. Kidney Int Suppl 69: S93-S106, 1999
20. Steiber AL, Davis AT, Spry L, Strong J, Buss ML, Ratkiewicz MM, Weatherspoon LJ: Carnitine treatment improved quality-of-life measure in a sample of Midwestern hemodialysis patients. JPEN J Parenter Enteral Nutr 30: 10-15, 2006
21. Hurot JM, Cucherat M, Haugh M, Fouque D: Effects of L-carnitine supplementation in maintenance hemodialysis patients: A systematic review. J Am Soc Nephrol 13: 708-714, 2002
22. Vernez L, Wenk M, Krähenbühl S: Determination of carnitine and acylcarnitines in plasma by high-performance liquid chromatography/ electrospray ionization ion trap tandem mass spectrometry. Rapid Commun Mass Spectrom 18: 1233-1238, 2004
23. Eknoyan G, Latos DL, Lindberg J; National Kidney Foundation Carnitine Consensus Conference: Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. Am J Kidney Dis 41: 868-876, 2003
24. KDOQI Clinical Practice guidelines for nutrition in children with CKD: 2008 update. Recommendation 9: carnitine. Am J Kidney Dis 53[3 suppl 2]: S75-S76, 2009
25. Murphy WJA, Steiber A, Connery GC, Carder J, Spry L, Hoppel C: Altered carnitine metabolism in dialysis patients with reduced physical function may be due to dysfunctional fatty acid oxidation. Nephrol Dial Transplant 27: 304-310, 2012
26. Adams SH, Hoppel CL, Lok KH, Zhao L, Wong SW, Minkler PE, Hwang DH, Newman JW, Garvey WT: Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid b-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. J Nutr 139: 1073-1081, 2009
27. Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD: Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 80: 299-307, 2004
28. Reuter SE, Faull RJ, Ranieri E, Evans AM: Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients. Nephrol Dial Transplant 24: 990-996, 2009